Evaluation of Flexible Conductive Hearing Aids
ConditionConductive Hearing Loss
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-80
SponsorWake Forest University Health Sciences
About this trial
Conductive hearing loss (CHL) is the most common type of hearing loss among the pediatric population. CHL occurs when sound is not properly transmitted from the external ear to the cochlea, and congenital pathologies like microtia/anotia, atresia, and absent or malformed ossicles make hearing loss permanent.
Eligibility criteria
Qualifiers
Male and female infants, children, adolescents, and adult patients who are diagnosed with unilateral or bilateral mixed or conductive hearing loss
Male and female patients seen at Atrium Health-Audiology for a clinical, standard of care office visit who have a diagnosis of conductive or mixed hearing loss and may currently wear hearing aids
Male and female infants, children, adolescents, and adults who are candidates for conductive hearing aids (Osseo-integrated or wearable aids) or for canalplasty or ossicular chain reconstruction surgery
Healthy subjects will include male and female infants, children, adolescents, and adults who do not have conductive or mixed hearing loss
Disqualifiers
Adult patients unable to independently understand the purpose of the study and the procedures and/or who are not willing to participate
Trial design
Treatments tested in this trial
- flexible conductive hearing aid
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov